{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-021526","form_type":"8-K","ticker":"LTRN","cik":"0001763950","company_name":"Lantern Pharma Inc.","filed_at":"2022-04-26T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.219007+00:00","generated_at":"2026-06-26T04:43:29.443196+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Lantern Pharma board nominee Maria Maccecchini; director Leslie Kreis not standing for reelection","bullets":["Leslie W. Kreis, Jr. will not stand for reelection at the June 8, 2022 annual meeting.","Maria L. Maccecchini, Ph.D., CEO of Annovis Bio (ANVS), nominated to the board.","She brings over 30 years biopharma experience in neurodegenerative disease and drug development.","Kreis served since 2019; CEO Panna Sharma thanked him for guiding Lantern through IPO and growth."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-021526","json":"https://secwatch.observer/filing/0001213900-22-021526.json","markdown":"https://secwatch.observer/filing/0001213900-22-021526.md","text":"https://secwatch.observer/filing/0001213900-22-021526.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1763950/000121390022021526/0001213900-22-021526-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1763950/000121390022021526/ea158857-8k_lantern.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T04:43:29.443196+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"58c76dd2b4","claim":"Leslie W. Kreis, Jr. departed as Director at Lantern Pharma Inc..","evidence_excerpt":"On April 20, 2022, Leslie W. Kreis, Jr. notified Lantern Pharma Inc. (the “Company”) that he will not stand for reelection to the Company’s Board of Directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1763950/000121390022021526/0001213900-22-021526-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"will not stand for reelection"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}